rs2229968

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017617.5(NOTCH1):​c.5011G>A​(p.Val1671Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00179 in 1,516,392 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 12 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 8 hom. )

Consequence

NOTCH1
NM_017617.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14O:1

Conservation

PhyloP100: -0.129

Publications

14 publications found
Variant links:
Genes affected
NOTCH1 (HGNC:7881): (notch receptor 1) This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]
NOTCH1 Gene-Disease associations (from GenCC):
  • Adams-Oliver syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • Adams-Oliver syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • aortic valve disease 1
    Inheritance: AD Classification: STRONG Submitted by: G2P, PanelApp Australia
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leukodystrophy
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial bicuspid aortic valve
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041054487).
BP6
Variant 9-136504680-C-T is Benign according to our data. Variant chr9-136504680-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 134940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00835 (1272/152322) while in subpopulation AFR AF = 0.0277 (1153/41560). AF 95% confidence interval is 0.0264. There are 12 homozygotes in GnomAd4. There are 603 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1272 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH1NM_017617.5 linkc.5011G>A p.Val1671Ile missense_variant Exon 26 of 34 ENST00000651671.1 NP_060087.3 P46531
NOTCH1XM_011518717.3 linkc.4288G>A p.Val1430Ile missense_variant Exon 23 of 31 XP_011517019.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH1ENST00000651671.1 linkc.5011G>A p.Val1671Ile missense_variant Exon 26 of 34 NM_017617.5 ENSP00000498587.1 P46531

Frequencies

GnomAD3 genomes
AF:
0.00830
AC:
1264
AN:
152204
Hom.:
12
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0276
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00464
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00245
AC:
306
AN:
125056
AF XY:
0.00216
show subpopulations
Gnomad AFR exome
AF:
0.0292
Gnomad AMR exome
AF:
0.00269
Gnomad ASJ exome
AF:
0.00262
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000160
Gnomad NFE exome
AF:
0.000460
Gnomad OTH exome
AF:
0.00220
GnomAD4 exome
AF:
0.00106
AC:
1444
AN:
1364070
Hom.:
8
Cov.:
33
AF XY:
0.000944
AC XY:
631
AN XY:
668660
show subpopulations
African (AFR)
AF:
0.0279
AC:
859
AN:
30778
American (AMR)
AF:
0.00341
AC:
113
AN:
33094
Ashkenazi Jewish (ASJ)
AF:
0.00209
AC:
48
AN:
23016
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35278
South Asian (SAS)
AF:
0.000468
AC:
35
AN:
74734
European-Finnish (FIN)
AF:
0.0000877
AC:
4
AN:
45624
Middle Eastern (MID)
AF:
0.00316
AC:
13
AN:
4116
European-Non Finnish (NFE)
AF:
0.000232
AC:
246
AN:
1061134
Other (OTH)
AF:
0.00224
AC:
126
AN:
56296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
84
169
253
338
422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00835
AC:
1272
AN:
152322
Hom.:
12
Cov.:
33
AF XY:
0.00810
AC XY:
603
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0277
AC:
1153
AN:
41560
American (AMR)
AF:
0.00464
AC:
71
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68018
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00265
Hom.:
5
Bravo
AF:
0.00971
ESP6500AA
AF:
0.0179
AC:
56
ESP6500EA
AF:
0.000296
AC:
2
ExAC
AF:
0.000989
AC:
74
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5Other:1
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 21, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NOTCH1: PP2, BP4, BS1, BS2 -

Nov 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:2
Nov 30, 2016
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 11, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Adams-Oliver syndrome 5 Benign:2
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aortic valve disease 1;C4014970:Adams-Oliver syndrome 5 Benign:1
Jul 02, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aortic valve disease 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
1.4
DANN
Benign
0.93
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
-0.13
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.28
N
REVEL
Benign
0.022
Sift
Benign
0.51
T
Sift4G
Benign
0.44
T
Polyphen
0.0060
B
Vest4
0.12
MVP
0.30
MPC
0.65
ClinPred
0.0021
T
GERP RS
-1.1
Varity_R
0.063
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229968; hg19: chr9-139399132; COSMIC: COSV53038538; API